Literature DB >> 6317508

Factors affecting the CEA secretion of human adenocarcinoma cell lines into the spent medium.

N Yamaguchi, K Kawai.   

Abstract

CEA producing cell lines were established from human gastric cancer (HGC-Y1), pancreatic cancer (HPC-Y9) and lung cancer (HLC-Y1). The culture medium was used RPMI-1640 supplemented with 10% fetal bovine serum. The secretion of carcinoembryonic antigen (CEA) into the spent medium from these cultured cell lines was modified by several factors, such as theophylline, cyclic AMP (cAMP), dibutyryl cyclic AMP (dbcAMP), Bromodeoxyuridine (BrdUrd), dimethyl sulfoxide (DMSO), Prostaglandin E2 (PGE2) and human interferon (INF). CEA secretion was enhanced by theophylline, cAMP, PGE2 and INF. Theophylline had an optimal dose to maximally enhance CEA secretion. cAMP and INF apparently enhanced CEA secretion dose dependently. PGE2 appeared to enhance CEA secretion, although cell growth was markedly suppressed dose dependently, dbcAMP, DMSO and BrdUrd did not affect CEA secretion. Here, the kinetics of CEA secretion was discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317508     DOI: 10.1007/bf02776581

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  37 in total

1.  Regulation of adenosine 3',5'-cyclic monophosphate metabolism in cultured neuroblastoma cells.

Authors:  A G Gilman; M Nirenberg
Journal:  Nature       Date:  1971-12-10       Impact factor: 49.962

2.  Identification of a developmental program using bromodeoxyuridine.

Authors:  H Weintraub; G L Campbell; H Holtzer
Journal:  J Mol Biol       Date:  1972-09-28       Impact factor: 5.469

3.  Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.

Authors:  J K Christman; S Silagi; E W Newcomb; S C Silverstein; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

4.  Stimulation of melanotic expression in a melanoma cell line by theophylline.

Authors:  M L Steinberg; J R Whittaker
Journal:  J Cell Physiol       Date:  1976-03       Impact factor: 6.384

5.  Specific changes in the surface glycoprotein pattern of human promyelocytic leukemic cell line HL-60 during morphologic and functional differentiation.

Authors:  C G Gahmberg; K Nilsson; L C Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

6.  The irreversible inhibition of differentiation of limb-bud mesenchyme by bromodeoxyuridine.

Authors:  D Levitt; A Dorfman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

7.  Stimulation of differentiated functions in human melanoma cells by tumor-promoting agents and dimethyl sulfoxide.

Authors:  E Huberman; C Heckman; R Langenbach
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

8.  Changes in histone phosphorylation and associated early metabolic events in pig lymphocyte cultures transformed by phytohaemagglutinin or 6-N,2'-O-dibutyryladenosine 3':5'-cyclic monophosphate.

Authors:  M E Cross; M G Ord
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

9.  Prostaglandin E 1 effects on adenosine 3':5'-cyclic monophosphate concentration and phosphodiesterase activity in fibroblasts (mouse L cells-tissue culture-enzyme kinetics-prostaglandin homologues).

Authors:  V Maganiello; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

10.  Restoration of contact-inhibited growth to transformed cells by dibutyryl adenosine 3':5'-cyclic monophosphate.

Authors:  J R Sheppard
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

View more
  2 in total

1.  Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4.

Authors:  S Akiyama; H Amo; T Watanabe; M Matsuyama; J Sakamoto; M Imaizumi; H Ichihashi; T Kondo; H Takagi
Journal:  Jpn J Surg       Date:  1988-07

2.  Cyclic-AMP-stimulated synthesis and release of carcinoembryonic antigen by pancreatic cancer cells.

Authors:  T L Sack; J R Gum; Y S Kim
Journal:  Int J Pancreatol       Date:  1988-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.